nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Pentoxifylline—systemic scleroderma	0.165	0.398	CbGbCtD
Levobupivacaine—CYP1A2—Leflunomide—systemic scleroderma	0.157	0.38	CbGbCtD
Levobupivacaine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0509	0.123	CbGbCtD
Levobupivacaine—CYP3A4—Prednisone—systemic scleroderma	0.0407	0.0984	CbGbCtD
Levobupivacaine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000498	0.00085	CcSEcCtD
Levobupivacaine—Muscular weakness—Prednisone—systemic scleroderma	0.000498	0.00085	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000498	0.000849	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000496	0.000846	CcSEcCtD
Levobupivacaine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000495	0.000844	CcSEcCtD
Levobupivacaine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00084	CcSEcCtD
Levobupivacaine—Insomnia—Leflunomide—systemic scleroderma	0.000492	0.00084	CcSEcCtD
Levobupivacaine—Abdominal distension—Prednisone—systemic scleroderma	0.000492	0.000839	CcSEcCtD
Levobupivacaine—Paraesthesia—Leflunomide—systemic scleroderma	0.000489	0.000833	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000488	0.000832	CcSEcCtD
Levobupivacaine—Arthralgia—Lisinopril—systemic scleroderma	0.000488	0.000832	CcSEcCtD
Levobupivacaine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000832	CcSEcCtD
Levobupivacaine—Anxiety—Lisinopril—systemic scleroderma	0.000486	0.000829	CcSEcCtD
Levobupivacaine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000828	CcSEcCtD
Levobupivacaine—Dyspnoea—Leflunomide—systemic scleroderma	0.000485	0.000828	CcSEcCtD
Levobupivacaine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000485	0.000827	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000484	0.000826	CcSEcCtD
Levobupivacaine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000823	CcSEcCtD
Levobupivacaine—Lethargy—Methotrexate—systemic scleroderma	0.000482	0.000822	CcSEcCtD
Levobupivacaine—Dyspepsia—Leflunomide—systemic scleroderma	0.000479	0.000817	CcSEcCtD
Levobupivacaine—Vomiting—Mometasone—systemic scleroderma	0.000478	0.000815	CcSEcCtD
Levobupivacaine—Sweating increased—Prednisone—systemic scleroderma	0.000476	0.000811	CcSEcCtD
Levobupivacaine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000475	0.00081	CcSEcCtD
Levobupivacaine—Asthenia—Captopril—systemic scleroderma	0.000474	0.000808	CcSEcCtD
Levobupivacaine—Decreased appetite—Leflunomide—systemic scleroderma	0.000473	0.000807	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000473	0.000807	CcSEcCtD
Levobupivacaine—Osteoarthritis—Methotrexate—systemic scleroderma	0.000472	0.000805	CcSEcCtD
Levobupivacaine—Confusional state—Lisinopril—systemic scleroderma	0.000472	0.000804	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000471	0.000804	CcSEcCtD
Levobupivacaine—Headache—Mometasone—systemic scleroderma	0.000471	0.000803	CcSEcCtD
Levobupivacaine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00047	0.000802	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00047	0.000801	CcSEcCtD
Levobupivacaine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00047	0.000801	CcSEcCtD
Levobupivacaine—Oedema—Lisinopril—systemic scleroderma	0.000468	0.000798	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000468	0.000798	CcSEcCtD
Levobupivacaine—Pruritus—Captopril—systemic scleroderma	0.000467	0.000797	CcSEcCtD
Levobupivacaine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000466	0.000795	CcSEcCtD
Levobupivacaine—Pain—Leflunomide—systemic scleroderma	0.000465	0.000794	CcSEcCtD
Levobupivacaine—Constipation—Leflunomide—systemic scleroderma	0.000465	0.000794	CcSEcCtD
Levobupivacaine—Infection—Lisinopril—systemic scleroderma	0.000465	0.000792	CcSEcCtD
Levobupivacaine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000464	0.000791	CcSEcCtD
Levobupivacaine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000463	0.000789	CcSEcCtD
Levobupivacaine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000462	0.000787	CcSEcCtD
Levobupivacaine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000461	0.000787	CcSEcCtD
Levobupivacaine—Shock—Lisinopril—systemic scleroderma	0.00046	0.000785	CcSEcCtD
Levobupivacaine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000782	CcSEcCtD
Levobupivacaine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000457	0.000779	CcSEcCtD
Levobupivacaine—Tachycardia—Lisinopril—systemic scleroderma	0.000456	0.000778	CcSEcCtD
Levobupivacaine—Abdominal pain—Azathioprine—systemic scleroderma	0.000456	0.000777	CcSEcCtD
Levobupivacaine—Body temperature increased—Azathioprine—systemic scleroderma	0.000456	0.000777	CcSEcCtD
Levobupivacaine—Skin disorder—Lisinopril—systemic scleroderma	0.000454	0.000775	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000452	0.000771	CcSEcCtD
Levobupivacaine—Diarrhoea—Captopril—systemic scleroderma	0.000452	0.000771	CcSEcCtD
Levobupivacaine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000451	0.00077	CcSEcCtD
Levobupivacaine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00045	0.000768	CcSEcCtD
Levobupivacaine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000448	0.000765	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000448	0.000764	CcSEcCtD
Levobupivacaine—Nausea—Mometasone—systemic scleroderma	0.000447	0.000762	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000445	0.000759	CcSEcCtD
Levobupivacaine—Pain—Mycophenolic acid—systemic scleroderma	0.000444	0.000757	CcSEcCtD
Levobupivacaine—Constipation—Mycophenolic acid—systemic scleroderma	0.000444	0.000757	CcSEcCtD
Levobupivacaine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000444	0.000757	CcSEcCtD
Levobupivacaine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000753	CcSEcCtD
Levobupivacaine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000438	0.000747	CcSEcCtD
Levobupivacaine—Hypotension—Lisinopril—systemic scleroderma	0.000437	0.000745	CcSEcCtD
Levobupivacaine—Dizziness—Captopril—systemic scleroderma	0.000437	0.000745	CcSEcCtD
Levobupivacaine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000742	CcSEcCtD
Levobupivacaine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000739	CcSEcCtD
Levobupivacaine—Urticaria—Leflunomide—systemic scleroderma	0.000432	0.000737	CcSEcCtD
Levobupivacaine—Abdominal pain—Leflunomide—systemic scleroderma	0.00043	0.000734	CcSEcCtD
Levobupivacaine—Body temperature increased—Leflunomide—systemic scleroderma	0.00043	0.000734	CcSEcCtD
Levobupivacaine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000428	0.00073	CcSEcCtD
Levobupivacaine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000729	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000427	0.000728	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000426	0.000727	CcSEcCtD
Levobupivacaine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000426	0.000726	CcSEcCtD
Levobupivacaine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000425	0.000724	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000425	0.000724	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000724	CcSEcCtD
Levobupivacaine—Insomnia—Lisinopril—systemic scleroderma	0.000423	0.000721	CcSEcCtD
Levobupivacaine—Paraesthesia—Lisinopril—systemic scleroderma	0.00042	0.000716	CcSEcCtD
Levobupivacaine—Vomiting—Captopril—systemic scleroderma	0.00042	0.000716	CcSEcCtD
Levobupivacaine—Dyspnoea—Lisinopril—systemic scleroderma	0.000417	0.000711	CcSEcCtD
Levobupivacaine—Somnolence—Lisinopril—systemic scleroderma	0.000416	0.000709	CcSEcCtD
Levobupivacaine—Headache—Captopril—systemic scleroderma	0.000414	0.000706	CcSEcCtD
Levobupivacaine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000705	CcSEcCtD
Levobupivacaine—Dyspepsia—Lisinopril—systemic scleroderma	0.000412	0.000702	CcSEcCtD
Levobupivacaine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00041	0.0007	CcSEcCtD
Levobupivacaine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00041	0.0007	CcSEcCtD
Levobupivacaine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000699	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00041	0.000699	CcSEcCtD
Levobupivacaine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000407	0.000694	CcSEcCtD
Levobupivacaine—Decreased appetite—Lisinopril—systemic scleroderma	0.000407	0.000693	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000404	0.000689	CcSEcCtD
Levobupivacaine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000403	0.000688	CcSEcCtD
Levobupivacaine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000402	0.000685	CcSEcCtD
Levobupivacaine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000401	0.000684	CcSEcCtD
Levobupivacaine—Pain—Lisinopril—systemic scleroderma	0.0004	0.000682	CcSEcCtD
Levobupivacaine—Constipation—Lisinopril—systemic scleroderma	0.0004	0.000682	CcSEcCtD
Levobupivacaine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.0004	0.000682	CcSEcCtD
Levobupivacaine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000679	CcSEcCtD
Levobupivacaine—Bradycardia—Prednisone—systemic scleroderma	0.000398	0.000679	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000396	0.000676	CcSEcCtD
Levobupivacaine—Diarrhoea—Azathioprine—systemic scleroderma	0.000394	0.000672	CcSEcCtD
Levobupivacaine—Nausea—Captopril—systemic scleroderma	0.000392	0.000669	CcSEcCtD
Levobupivacaine—Asthenia—Leflunomide—systemic scleroderma	0.00039	0.000666	CcSEcCtD
Levobupivacaine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000385	0.000657	CcSEcCtD
Levobupivacaine—Pruritus—Leflunomide—systemic scleroderma	0.000385	0.000657	CcSEcCtD
Levobupivacaine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000653	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000382	0.000652	CcSEcCtD
Levobupivacaine—Dizziness—Azathioprine—systemic scleroderma	0.000381	0.00065	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000373	0.000637	CcSEcCtD
Levobupivacaine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000373	0.000635	CcSEcCtD
Levobupivacaine—Diarrhoea—Leflunomide—systemic scleroderma	0.000372	0.000635	CcSEcCtD
Levobupivacaine—Urticaria—Lisinopril—systemic scleroderma	0.000372	0.000634	CcSEcCtD
Levobupivacaine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000371	0.000632	CcSEcCtD
Levobupivacaine—Body temperature increased—Lisinopril—systemic scleroderma	0.00037	0.00063	CcSEcCtD
Levobupivacaine—Abdominal pain—Lisinopril—systemic scleroderma	0.00037	0.00063	CcSEcCtD
Levobupivacaine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000627	CcSEcCtD
Levobupivacaine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000367	0.000626	CcSEcCtD
Levobupivacaine—Vomiting—Azathioprine—systemic scleroderma	0.000366	0.000625	CcSEcCtD
Levobupivacaine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000623	CcSEcCtD
Levobupivacaine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000364	0.000621	CcSEcCtD
Levobupivacaine—Infestation NOS—Methotrexate—systemic scleroderma	0.000364	0.000621	CcSEcCtD
Levobupivacaine—Infestation—Methotrexate—systemic scleroderma	0.000364	0.000621	CcSEcCtD
Levobupivacaine—Drowsiness—Methotrexate—systemic scleroderma	0.000364	0.000621	CcSEcCtD
Levobupivacaine—Flushing—Prednisone—systemic scleroderma	0.000363	0.000619	CcSEcCtD
Levobupivacaine—Headache—Azathioprine—systemic scleroderma	0.000361	0.000616	CcSEcCtD
Levobupivacaine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000361	0.000615	CcSEcCtD
Levobupivacaine—Dizziness—Leflunomide—systemic scleroderma	0.00036	0.000614	CcSEcCtD
Levobupivacaine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000356	0.000607	CcSEcCtD
Levobupivacaine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000355	0.000606	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000603	CcSEcCtD
Levobupivacaine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000598	CcSEcCtD
Levobupivacaine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000598	CcSEcCtD
Levobupivacaine—Arrhythmia—Prednisone—systemic scleroderma	0.000349	0.000596	CcSEcCtD
Levobupivacaine—Sweating—Methotrexate—systemic scleroderma	0.000349	0.000595	CcSEcCtD
Levobupivacaine—Haematuria—Methotrexate—systemic scleroderma	0.000347	0.000592	CcSEcCtD
Levobupivacaine—Vomiting—Leflunomide—systemic scleroderma	0.000346	0.00059	CcSEcCtD
Levobupivacaine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000345	0.000588	CcSEcCtD
Levobupivacaine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000343	0.000586	CcSEcCtD
Levobupivacaine—Mental disorder—Prednisone—systemic scleroderma	0.000343	0.000584	CcSEcCtD
Levobupivacaine—Nausea—Azathioprine—systemic scleroderma	0.000342	0.000584	CcSEcCtD
Levobupivacaine—Headache—Leflunomide—systemic scleroderma	0.000341	0.000581	CcSEcCtD
Levobupivacaine—Malnutrition—Prednisone—systemic scleroderma	0.00034	0.00058	CcSEcCtD
Levobupivacaine—Erythema—Prednisone—systemic scleroderma	0.00034	0.00058	CcSEcCtD
Levobupivacaine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000576	CcSEcCtD
Levobupivacaine—Asthenia—Lisinopril—systemic scleroderma	0.000336	0.000572	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000571	CcSEcCtD
Levobupivacaine—Pruritus—Lisinopril—systemic scleroderma	0.000331	0.000564	CcSEcCtD
Levobupivacaine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00033	0.000563	CcSEcCtD
Levobupivacaine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000555	CcSEcCtD
Levobupivacaine—Headache—Mycophenolic acid—systemic scleroderma	0.000325	0.000555	CcSEcCtD
Levobupivacaine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000552	CcSEcCtD
Levobupivacaine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000552	CcSEcCtD
Levobupivacaine—Nausea—Leflunomide—systemic scleroderma	0.000323	0.000551	CcSEcCtD
Levobupivacaine—Vision blurred—Prednisone—systemic scleroderma	0.000321	0.000547	CcSEcCtD
Levobupivacaine—Diarrhoea—Lisinopril—systemic scleroderma	0.00032	0.000546	CcSEcCtD
Levobupivacaine—Anaemia—Prednisone—systemic scleroderma	0.000315	0.000536	CcSEcCtD
Levobupivacaine—Agitation—Prednisone—systemic scleroderma	0.000313	0.000533	CcSEcCtD
Levobupivacaine—Angioedema—Prednisone—systemic scleroderma	0.000311	0.00053	CcSEcCtD
Levobupivacaine—Dizziness—Lisinopril—systemic scleroderma	0.000309	0.000527	CcSEcCtD
Levobupivacaine—Nausea—Mycophenolic acid—systemic scleroderma	0.000308	0.000526	CcSEcCtD
Levobupivacaine—Syncope—Prednisone—systemic scleroderma	0.000305	0.00052	CcSEcCtD
Levobupivacaine—Tinnitus—Methotrexate—systemic scleroderma	0.000305	0.00052	CcSEcCtD
Levobupivacaine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000303	0.000517	CcSEcCtD
Levobupivacaine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000515	CcSEcCtD
Levobupivacaine—Loss of consciousness—Prednisone—systemic scleroderma	0.000299	0.00051	CcSEcCtD
Levobupivacaine—Vomiting—Lisinopril—systemic scleroderma	0.000297	0.000507	CcSEcCtD
Levobupivacaine—Convulsion—Prednisone—systemic scleroderma	0.000295	0.000503	CcSEcCtD
Levobupivacaine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000294	0.000501	CcSEcCtD
Levobupivacaine—Hypertension—Prednisone—systemic scleroderma	0.000294	0.000501	CcSEcCtD
Levobupivacaine—Chills—Methotrexate—systemic scleroderma	0.000293	0.0005	CcSEcCtD
Levobupivacaine—Headache—Lisinopril—systemic scleroderma	0.000293	0.0005	CcSEcCtD
Levobupivacaine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000494	CcSEcCtD
Levobupivacaine—Arthralgia—Prednisone—systemic scleroderma	0.00029	0.000494	CcSEcCtD
Levobupivacaine—Anxiety—Prednisone—systemic scleroderma	0.000289	0.000492	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000288	0.000491	CcSEcCtD
Levobupivacaine—Mental disorder—Methotrexate—systemic scleroderma	0.000286	0.000488	CcSEcCtD
Levobupivacaine—Erythema—Methotrexate—systemic scleroderma	0.000284	0.000485	CcSEcCtD
Levobupivacaine—Malnutrition—Methotrexate—systemic scleroderma	0.000284	0.000485	CcSEcCtD
Levobupivacaine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000478	CcSEcCtD
Levobupivacaine—Nausea—Lisinopril—systemic scleroderma	0.000278	0.000474	CcSEcCtD
Levobupivacaine—Oedema—Prednisone—systemic scleroderma	0.000278	0.000474	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000278	0.000474	CcSEcCtD
Levobupivacaine—Infection—Prednisone—systemic scleroderma	0.000276	0.000471	CcSEcCtD
Levobupivacaine—Back pain—Methotrexate—systemic scleroderma	0.000275	0.000469	CcSEcCtD
Levobupivacaine—Shock—Prednisone—systemic scleroderma	0.000273	0.000466	CcSEcCtD
Levobupivacaine—Nervous system disorder—Prednisone—systemic scleroderma	0.000272	0.000465	CcSEcCtD
Levobupivacaine—Tachycardia—Prednisone—systemic scleroderma	0.000271	0.000462	CcSEcCtD
Levobupivacaine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000462	CcSEcCtD
Levobupivacaine—Skin disorder—Prednisone—systemic scleroderma	0.00027	0.00046	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000269	0.000458	CcSEcCtD
Levobupivacaine—Vision blurred—Methotrexate—systemic scleroderma	0.000268	0.000457	CcSEcCtD
Levobupivacaine—Anaemia—Methotrexate—systemic scleroderma	0.000263	0.000448	CcSEcCtD
Levobupivacaine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000444	CcSEcCtD
Levobupivacaine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000438	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000253	0.000432	CcSEcCtD
Levobupivacaine—Insomnia—Prednisone—systemic scleroderma	0.000251	0.000428	CcSEcCtD
Levobupivacaine—Paraesthesia—Prednisone—systemic scleroderma	0.000249	0.000425	CcSEcCtD
Levobupivacaine—Cough—Methotrexate—systemic scleroderma	0.000248	0.000423	CcSEcCtD
Levobupivacaine—Convulsion—Methotrexate—systemic scleroderma	0.000246	0.00042	CcSEcCtD
Levobupivacaine—Dyspepsia—Prednisone—systemic scleroderma	0.000244	0.000417	CcSEcCtD
Levobupivacaine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000415	CcSEcCtD
Levobupivacaine—Arthralgia—Methotrexate—systemic scleroderma	0.000242	0.000413	CcSEcCtD
Levobupivacaine—Decreased appetite—Prednisone—systemic scleroderma	0.000241	0.000412	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00024	0.00041	CcSEcCtD
Levobupivacaine—Constipation—Prednisone—systemic scleroderma	0.000238	0.000405	CcSEcCtD
Levobupivacaine—Confusional state—Methotrexate—systemic scleroderma	0.000234	0.000399	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000232	0.000396	CcSEcCtD
Levobupivacaine—Infection—Methotrexate—systemic scleroderma	0.000231	0.000393	CcSEcCtD
Levobupivacaine—Feeling abnormal—Prednisone—systemic scleroderma	0.000229	0.00039	CcSEcCtD
Levobupivacaine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000228	0.000388	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000227	0.000387	CcSEcCtD
Levobupivacaine—Skin disorder—Methotrexate—systemic scleroderma	0.000225	0.000385	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000224	0.000383	CcSEcCtD
Levobupivacaine—Urticaria—Prednisone—systemic scleroderma	0.000221	0.000376	CcSEcCtD
Levobupivacaine—Abdominal pain—Prednisone—systemic scleroderma	0.00022	0.000374	CcSEcCtD
Levobupivacaine—Body temperature increased—Prednisone—systemic scleroderma	0.00022	0.000374	CcSEcCtD
Levobupivacaine—Hypotension—Methotrexate—systemic scleroderma	0.000217	0.00037	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000211	0.000361	CcSEcCtD
Levobupivacaine—Insomnia—Methotrexate—systemic scleroderma	0.00021	0.000358	CcSEcCtD
Levobupivacaine—Paraesthesia—Methotrexate—systemic scleroderma	0.000208	0.000355	CcSEcCtD
Levobupivacaine—Dyspnoea—Methotrexate—systemic scleroderma	0.000207	0.000353	CcSEcCtD
Levobupivacaine—Somnolence—Methotrexate—systemic scleroderma	0.000206	0.000352	CcSEcCtD
Levobupivacaine—Hypersensitivity—Prednisone—systemic scleroderma	0.000205	0.000349	CcSEcCtD
Levobupivacaine—Dyspepsia—Methotrexate—systemic scleroderma	0.000204	0.000348	CcSEcCtD
Levobupivacaine—Decreased appetite—Methotrexate—systemic scleroderma	0.000202	0.000344	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.0002	0.000342	CcSEcCtD
Levobupivacaine—Asthenia—Prednisone—systemic scleroderma	0.000199	0.00034	CcSEcCtD
Levobupivacaine—Pain—Methotrexate—systemic scleroderma	0.000198	0.000339	CcSEcCtD
Levobupivacaine—Pruritus—Prednisone—systemic scleroderma	0.000197	0.000335	CcSEcCtD
Levobupivacaine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000191	0.000326	CcSEcCtD
Levobupivacaine—Diarrhoea—Prednisone—systemic scleroderma	0.00019	0.000324	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00019	0.000324	CcSEcCtD
Levobupivacaine—Urticaria—Methotrexate—systemic scleroderma	0.000184	0.000314	CcSEcCtD
Levobupivacaine—Dizziness—Prednisone—systemic scleroderma	0.000184	0.000313	CcSEcCtD
Levobupivacaine—Abdominal pain—Methotrexate—systemic scleroderma	0.000183	0.000313	CcSEcCtD
Levobupivacaine—Body temperature increased—Methotrexate—systemic scleroderma	0.000183	0.000313	CcSEcCtD
Levobupivacaine—Vomiting—Prednisone—systemic scleroderma	0.000177	0.000301	CcSEcCtD
Levobupivacaine—Headache—Prednisone—systemic scleroderma	0.000174	0.000297	CcSEcCtD
Levobupivacaine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000171	0.000292	CcSEcCtD
Levobupivacaine—Asthenia—Methotrexate—systemic scleroderma	0.000167	0.000284	CcSEcCtD
Levobupivacaine—Nausea—Prednisone—systemic scleroderma	0.000165	0.000281	CcSEcCtD
Levobupivacaine—Pruritus—Methotrexate—systemic scleroderma	0.000164	0.00028	CcSEcCtD
Levobupivacaine—Diarrhoea—Methotrexate—systemic scleroderma	0.000159	0.000271	CcSEcCtD
Levobupivacaine—Dizziness—Methotrexate—systemic scleroderma	0.000153	0.000262	CcSEcCtD
Levobupivacaine—Vomiting—Methotrexate—systemic scleroderma	0.000148	0.000252	CcSEcCtD
Levobupivacaine—Headache—Methotrexate—systemic scleroderma	0.000145	0.000248	CcSEcCtD
Levobupivacaine—Nausea—Methotrexate—systemic scleroderma	0.000138	0.000235	CcSEcCtD
